EV Biotech

EV Biotech develops and optimizes microbial production strains for bio-based products using a proprietary AI platform called Artemis. The company combines metabolic modeling with machine learning to engineer regulatory pathways and validate high-performance microbes in their own laboratory. They partner with organizations to transition products from early strain engineering to industrial-scale fermentation through co-development agreements, licenses, and joint ventures.